Mostrar el registro sencillo del ítem
dc.contributor.author | Valdivia, M. | |
dc.contributor.author | Soto Becerra, Percy | |
dc.contributor.author | Laguna-Barraza, R. | |
dc.contributor.author | Rojas, P.A. | |
dc.contributor.author | Reyes-Mandujano, I. | |
dc.contributor.author | Gonzáles-Reyes, P. | |
dc.contributor.author | Temoche, H. | |
dc.contributor.author | Timoteo, O.S. | |
dc.contributor.author | Lugo-Martinez, G. | |
dc.contributor.author | Calzada-Mendoza, C.C. | |
dc.contributor.author | Mezones-Holguin, E. | |
dc.date.accessioned | 2020-12-14T16:10:22Z | |
dc.date.available | 2020-12-14T16:10:22Z | |
dc.date.issued | 2020 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/8837 | |
dc.description.abstract | Objective: To evaluate the effect of a herbal preparation containing glucosinolates, phytosterols and citrus flavonoids (supplement) on body weight and metabolic parameters usually impaired by menopause. Methods: A pre-clinical experimental study carried out in twenty-five Swiss strain mice (Mus musculus) randomly distributed (1:1:1:1:1 ratio) to five groups to receive for ten weeks: (1) oral gelatinized maca extract 0.5625 mg/kg/day + bilateral ovariectomy (Maca + OVX); (2) oral supplement 0.5625 mg/kg/day + bilateral ovariectomy (S1 + OVX); (3) oral supplement 1.6875 mg/kg/day + bilateral ovariectomy (S2 + OVX); (4) oral saline 100 µl/kg/day + bilateral ovariectomy (OVX); and (5) oral saline 100 µl/kg/day + sham surgery (sham). The primary endpoint was change in body weight gain from baseline to final. Secondary endpoints were uterine weight and cholesterol, triglyceride, glucose, and glucose/triglycerides index values at the end of the study. A modified intention-to-treat analysis was performed through linear regression models and using the Bonferroni method to penalized p-values by multiple comparisons. Results: Twenty-three animals completed the study. There was a significant average difference in weight gain, with a greater reduction in the S2 + OVX group compared to the OVX group (difference= −3.5; 95% CI (–5.27; −1.74); p <.001). S2 + OVX group also displayed a significant average reduction of total blood cholesterol (difference: −16.94; 95% CI (–33.73; −0.15); p =.037). No significant effects of the supplement were found on other secondary endpoints. Conclusion: In this murine menopausal model, triple oral supplement dose resulted in an average reduction of weight gain and total cholesterol levels, suggesting that the compound could have a potential effect at regulating menopausal altered metabolism. | en_US |
dc.language.iso | eng | |
dc.publisher | Taylor and Francis | |
dc.relation.ispartofseries | Gynecological Endocrinology | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Lepidium Meyenii | en_US |
dc.subject | supplementation | en_US |
dc.subject | glucosinolates | en_US |
dc.subject | phytosterol | en_US |
dc.subject | citrus flavonoids | en_US |
dc.subject | menopause | en_US |
dc.subject | body weight | en_US |
dc.subject | metabolism | en_US |
dc.title | Effect of a natural supplement containing glucosinolates, phytosterols and citrus flavonoids on body weight and metabolic parameters in a menopausal murine model induced by bilateral ovariectomy | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1080/09513590.2020.1821639 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.18 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.02 | |
dc.relation.issn | 1473-0766 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |